49 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
27 Oct 23
Regulation FD Disclosure
4:19pm
complications include hyperacute graft-versus-host-disease (GVHD), acute GVHD, chronic GVHD, hepatic veno-occlusive disease (VOD) after reduced intensity
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
5 Nov 20
Coherus BioSciences Reports Third Quarter 2020 Financial Results
4:07pm
biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and expand patient access. Composed
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
6 Aug 20
Coherus BioSciences Appoints Kimberly Tzoumakas, J.D. to Board of Directors
4:19pm
access to the United States market. Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life
8-K
EX-99.1
2pe2 1dnm2bh4j9d
7 May 20
Coherus BioSciences Reports First Quarter 2020 Financial Results
4:02pm
8-K
EX-99.2
m1g1nlpm y40f
17 Apr 20
Coherus BioSciences Announces Proposed Convertible Senior Subordinated Notes Offering
4:24pm
8-K
EX-99.1
vi10vspuezz
17 Apr 20
Coherus BioSciences Announces Proposed Convertible Senior Subordinated Notes Offering
4:24pm
8-K
EX-99.1
n580gsvkz4 qr
27 Feb 20
Coherus BioSciences Reports Fourth Quarter and Full Year 2019 Financial Results
4:16pm
8-K
EX-99.1
n6uq7 mqsdxmg
6 Nov 19
Coherus BioSciences Reports Corporate Highlights and Third Quarter 2019 Financial Results
4:38pm
8-K
EX-99.1
d3rs5ht 3kxepni
1 Aug 19
Second Quarter 2019 Financial Results
4:23pm
8-K
EX-99.1
bmxl9lbev3krof62ff9g
8 Jul 19
Results of Operations and Financial Condition
4:11pm
8-K
EX-99.1
ddaa1d e7os5rb
9 May 19
First Quarter 2019 Financial Results
4:08pm
8-K
EX-99.1
3lj9rv3o
3 May 19
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-99.1
cz3uua0ulq9pby
5 Apr 19
Coherus BioSciences Announces Unaudited First Quarter 2019 UDENYCA™ Net Sales
4:13pm
8-K
EX-99.1
zokpu
19 Mar 19
Coherus BioSciences Receives Transitional
4:05pm
8-K
EX-99.1
n6oaqzftka3
28 Feb 19
Coherus BioSciences Reports Fourth Quarter and Full Year 2018 Financial Results
4:11pm